Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans
- PMID: 24576874
- DOI: 10.1167/iovs.13-13784
Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans
Abstract
Purpose: The Age-Related Eye Disease Study 1 (AREDS 1) has shown that nutritional supplementation with antioxidants and zinc modifies the natural course of AMD. It is presumed that the supplements exert their beneficial effects by ameliorating oxidative stress due to the scavenging of reactive oxygen species (ROS). We have shown in a human model that under oxidative stress induced by administration of lipopolysaccharide (LPS) the vasoconstrictor response of retinal vessels to oxygen breathing is diminished. This reduced vascular response to hyperoxia was previously shown to be normalized by the AREDS 1 supplements. In the present study, we tested the hypothesis that the response can also be restored by a different antioxidant formulation.
Methods: This randomized, double-masked, placebo-controlled parallel group study included 40 healthy volunteers. On each study day, retinal red blood cell (RBC) flow and the reactivity of retinal RBC flow to hyperoxia were investigated in the absence and presence of 2 ng/kg LPS. Between the two study days, subjects received either the supplement or placebo for 14 days.
Results: Before supplementation LPS reduced retinal arterial vasoconstriction (P < 0.001) and reactivity of retinal RBC flow (P = 0.03) in response to 100% oxygen breathing. Two weeks of supplementation did not affect baseline retinal RBC flow, but normalized the LPS-induced change in the response to hyperoxia. The arterial vasoconstrictor response during LPS and 100% oxygen breathing was 4.1 ± 1.0% after administration of placebo and 10.6 ± 0.9% after supplementation (P = 0.005). The response of RBC flow to 100% oxygen breathing during LPS was 52.2 ± 2.1% after administration of placebo and 59.5 ± 2.0% after supplementation (P = 0.033).
Conclusions: Our data show that the supplement used in the present study can normalize the response of retinal RBC flow to hyperoxia under LPS administration. This indicates that supplementation can prevent endothelial dysfunction induced by oxidative stress, which is assumed to play a role in the pathophysiology of AMD. (ClinicalTrials.gov number, NCT00914576.).
Keywords: healthy subjects; nutritional supplementation; oxygen; retinal blood flow regulation.
Similar articles
-
Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model.Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):403-11. doi: 10.1167/iovs.14-15581. Invest Ophthalmol Vis Sci. 2014. PMID: 25525163 Clinical Trial.
-
Effects of antioxidants (AREDS medication) on ocular blood flow and endothelial function in an endotoxin-induced model of oxidative stress in humans.Invest Ophthalmol Vis Sci. 2010 Jan;51(1):2-6. doi: 10.1167/iovs.09-3888. Epub 2009 Aug 13. Invest Ophthalmol Vis Sci. 2010. PMID: 19684008 Clinical Trial.
-
Effects of vitamin C on hyperoxia-induced reduction of retinal blood flow.Microvasc Res. 2009 May;77(3):256-9. doi: 10.1016/j.mvr.2008.12.002. Epub 2008 Dec 29. Microvasc Res. 2009. PMID: 19159632
-
Nutrition and retina.Dev Ophthalmol. 2005;38:120-147. doi: 10.1159/000082772. Dev Ophthalmol. 2005. PMID: 15604621 Review.
-
Vitamin and antioxidant supplementation: critical evaluation of clinical outcomes.Nestle Nutr Workshop Ser Clin Perform Programme. 2002;7:119-30; discussions 130-2. doi: 10.1159/000067514. Nestle Nutr Workshop Ser Clin Perform Programme. 2002. PMID: 12481698 Review. No abstract available.
Cited by
-
Beneficial Effect of Long-Term Administration of Supplement With Trapa Bispinosa Roxb. and Lutein on Retinal Neurovascular Coupling in Type 2 Diabetic Mice.Front Physiol. 2022 Feb 24;13:788034. doi: 10.3389/fphys.2022.788034. eCollection 2022. Front Physiol. 2022. PMID: 35283788 Free PMC article.
-
Time Course of Plasma Proteomic and Oxylipin Changes Induced by LPS Challenge and Modulated by Antioxidant Supplementation in a Randomized Controlled Trial.Antioxidants (Basel). 2025 Apr 29;14(5):536. doi: 10.3390/antiox14050536. Antioxidants (Basel). 2025. PMID: 40427419 Free PMC article.
-
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Sep 13;9:CD000254. doi: 10.1002/14651858.CD000254.pub5. PMID: 28756618 Free PMC article. Updated.
-
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5. Cochrane Database Syst Rev. 2023. PMID: 37702300 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical